• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素的有丝分裂作用:朋友、敌人还是“敌友”?

Mitogenic action of insulin: friend, foe or 'frenemy'?

机构信息

Adult Diabetes Program, University of Colorado Denver, Mail Stop 8106, 12631 E 17th Ave, Aurora, CO 80045, USA.

出版信息

Diabetologia. 2010 Feb;53(2):229-33. doi: 10.1007/s00125-009-1558-6. Epub 2009 Oct 23.

DOI:10.1007/s00125-009-1558-6
PMID:19851749
Abstract

Either endogenous or exogenous hyperinsulinaemia in the setting of insulin resistance promotes phosphorylation and activation of farnesyltransferase, a ubiquitous enzyme that farnesylates Ras proteins. Increased availability of farnesylated Ras at the plasma membrane enhances mitogenic responsiveness of cells to various growth factors, thus contributing to progression of cancer and atherosclerosis. This effect is specific to insulin, but is not related to the type of insulin used. The stimulatory effect of hyperinsulinaemia on farnesyltransferase in the presence of insulin resistance represents one potential mechanism responsible for mitogenicity and atherogenicity of insulin.

摘要

无论是内源性还是外源性的胰岛素抵抗引起的高胰岛素血症,都会促进法呢基转移酶的磷酸化和激活。法呢基转移酶是一种普遍存在的酶,可将 Ras 蛋白法尼基化。质膜中法尼基化 Ras 的可用性增加,增强了细胞对各种生长因子的有丝分裂反应性,从而促进了癌症和动脉粥样硬化的发展。这种作用是胰岛素特有的,但与所用胰岛素的类型无关。在胰岛素抵抗存在的情况下,高胰岛素血症对法呢基转移酶的刺激作用代表了胰岛素促有丝分裂和动脉粥样硬化作用的一个潜在机制。

相似文献

1
Mitogenic action of insulin: friend, foe or 'frenemy'?胰岛素的有丝分裂作用:朋友、敌人还是“敌友”?
Diabetologia. 2010 Feb;53(2):229-33. doi: 10.1007/s00125-009-1558-6. Epub 2009 Oct 23.
2
Mechanism of the mitogenic influence of hyperinsulinemia.高胰岛素血症促有丝分裂影响的机制。
Diabetol Metab Syndr. 2011 Jun 13;3(1):10. doi: 10.1186/1758-5996-3-10.
3
Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine.胰岛素抵抗与恶性肿瘤风险增加:甘精胰岛素数据的混杂因素
Diabetologia. 2010 Jan;53(1):206-8. doi: 10.1007/s00125-009-1535-0. Epub 2009 Sep 24.
4
[Diabetes, insulin, insulin analogues, and cancer].[糖尿病、胰岛素、胰岛素类似物与癌症]
Dtsch Med Wochenschr. 2010 May;135(18):924-9. doi: 10.1055/s-0030-1253681. Epub 2010 Apr 27.
5
Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues.甘精胰岛素治疗糖尿病与恶性肿瘤风险:方法学缺陷与伦理问题
Diabetologia. 2010 Jan;53(1):204-5. doi: 10.1007/s00125-009-1572-8. Epub 2009 Oct 27.
6
Insulin glargine and incidence of cancer--an ongoing debate.甘精胰岛素与癌症发病率——一场仍在进行的争论。
J Diabetes Sci Technol. 2010 Mar 1;4(2):497-8. doi: 10.1177/193229681000400235.
7
[Increased risk of cancer using insulin and insulin analogues?].使用胰岛素和胰岛素类似物会增加患癌风险吗?
MMW Fortschr Med. 2010 Sep 9;152(36):39-41. doi: 10.1007/BF03366975.
8
Insulin glargine controversy: a tribute to the editorial team at Diabetologia.甘精胰岛素之争:向《糖尿病学》编辑团队致敬。
Diabetes. 2009 Nov;58(11):2427-8. doi: 10.2337/db09-9030.
9
Risk of cancer in patients receiving insulin glargine.接受甘精胰岛素治疗的患者的癌症风险。
Am J Health Syst Pharm. 2010 Dec 1;67(23):2025-31. doi: 10.2146/ajhp100109.
10
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.糖尿病患者使用人胰岛素或胰岛素类似物治疗的恶性肿瘤风险:一项队列研究。
Diabetologia. 2009 Sep;52(9):1732-44. doi: 10.1007/s00125-009-1418-4. Epub 2009 Jun 30.

引用本文的文献

1
The Interlinking Metabolic Association between Type 2 Diabetes Mellitus and Cancer: Molecular Mechanisms and Therapeutic Insights.2型糖尿病与癌症之间的相互关联代谢联系:分子机制与治疗见解
Diagnostics (Basel). 2024 Sep 25;14(19):2132. doi: 10.3390/diagnostics14192132.
2
Influence of Type 2 Diabetes and Adipose Tissue Dysfunction on Breast Cancer and Potential Benefits from Nutraceuticals Inducible in Microalgae.2 型糖尿病和脂肪组织功能障碍对乳腺癌的影响,以及微藻中诱导的营养保健品的潜在益处。
Nutrients. 2024 Sep 25;16(19):3243. doi: 10.3390/nu16193243.
3
Ketosis Suppression and Ageing (KetoSAge) Part 2: The Effect of Suppressing Ketosis on Biomarkers Associated with Ageing, HOMA-IR, Leptin, Osteocalcin, and GLP-1, in Healthy Females.

本文引用的文献

1
Does diabetes therapy influence the risk of cancer?糖尿病治疗会影响患癌风险吗?
Diabetologia. 2009 Sep;52(9):1699-708. doi: 10.1007/s00125-009-1441-5.
2
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden.甘精胰岛素的使用与短期恶性肿瘤发病风险:一项基于人群的瑞典随访研究。
Diabetologia. 2009 Sep;52(9):1745-54. doi: 10.1007/s00125-009-1444-2. Epub 2009 Jul 9.
3
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.降糖治疗对 2 型糖尿病患者癌症风险的影响。
酮症抑制与衰老(KetoSAge)第二部分:抑制酮症对健康女性中与衰老相关的生物标志物、胰岛素抵抗指数(HOMA-IR)、瘦素、骨钙素和胰高血糖素样肽-1的影响。
Biomedicines. 2024 Jul 12;12(7):1553. doi: 10.3390/biomedicines12071553.
4
Aging and "Age-Related" Diseases - What Is the Relation?衰老与“年龄相关”疾病——二者有何关系?
Aging Dis. 2024 Jun 28;16(3):1316-1346. doi: 10.14336/AD.2024.0570.
5
Ketosis Suppression and Ageing (KetoSAge): The Effects of Suppressing Ketosis in Long Term Keto-Adapted Non-Athletic Females.酮症抑制与衰老(KetoSAge):长期生酮适应的非运动女性抑制酮症的影响。
Int J Mol Sci. 2023 Oct 26;24(21):15621. doi: 10.3390/ijms242115621.
6
Bio-Hacking Better Health-Leveraging Metabolic Biochemistry to Maximise Healthspan.生物黑客助力健康——利用代谢生物化学最大化健康寿命。
Antioxidants (Basel). 2023 Sep 11;12(9):1749. doi: 10.3390/antiox12091749.
7
Insulin signaling and its application.胰岛素信号转导及其应用。
Front Endocrinol (Lausanne). 2023 Aug 17;14:1226655. doi: 10.3389/fendo.2023.1226655. eCollection 2023.
8
Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia.良性前列腺增生中雄激素非依赖性基质细胞增殖的机制。
Int J Mol Sci. 2023 Jul 19;24(14):11634. doi: 10.3390/ijms241411634.
9
miRNA deregulation and relationship with metabolic parameters after Mediterranean dietary intervention in BRCA-mutated women.BRCA 突变女性接受地中海饮食干预后 miRNA 的失调及其与代谢参数的关系
Front Oncol. 2023 Apr 4;13:1147190. doi: 10.3389/fonc.2023.1147190. eCollection 2023.
10
Glycemic index, glycemic load, and lung cancer risk: A meta-analysis of cohort and case-control studies.血糖指数、血糖负荷与肺癌风险:队列研究和病例对照研究的荟萃分析。
PLoS One. 2022 Sep 1;17(9):e0273943. doi: 10.1371/journal.pone.0273943. eCollection 2022.
Diabetologia. 2009 Sep;52(9):1766-77. doi: 10.1007/s00125-009-1440-6. Epub 2009 Jul 2.
4
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.糖尿病患者使用人胰岛素或胰岛素类似物治疗的恶性肿瘤风险:一项队列研究。
Diabetologia. 2009 Sep;52(9):1732-44. doi: 10.1007/s00125-009-1418-4. Epub 2009 Jun 30.
5
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.二甲双胍与糖尿病乳腺癌患者对新辅助化疗的病理完全缓解
J Clin Oncol. 2009 Jul 10;27(20):3297-302. doi: 10.1200/JCO.2009.19.6410. Epub 2009 Jun 1.
6
Diet, delusion and diabetes.饮食、错觉与糖尿病。
Diabetologia. 2009 Jan;52(1):1-7. doi: 10.1007/s00125-008-1203-9.
7
Effects of chronic hyperinsulinemia in insulin-resistant patients.慢性高胰岛素血症对胰岛素抵抗患者的影响。
Curr Diab Rep. 2008 Jun;8(3):233-8. doi: 10.1007/s11892-008-0040-z.
8
Increased farnesylation of p21-Ras and neonatal macrosomia in women with gestational diabetes.妊娠期糖尿病女性中p21-Ras法尼基化增加与新生儿巨大儿
J Pediatr. 2006 Dec;149(6):871-3. doi: 10.1016/j.jpeds.2006.08.071.
9
Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.使用磺脲类药物或胰岛素的2型糖尿病患者癌症相关死亡率增加。
Diabetes Care. 2006 Feb;29(2):254-8. doi: 10.2337/diacare.29.02.06.dc05-1558.
10
Molecular mechanisms of insulin resistance that impact cardiovascular biology.影响心血管生物学的胰岛素抵抗分子机制。
Diabetes. 2004 Nov;53(11):2735-40. doi: 10.2337/diabetes.53.11.2735.